Natural killer cell therapy for advanced stomach and colorectal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial studies an experimental cell therapy called NK510 for people with advanced stomach or colorectal cancer that has not responded to standard treatments. The therapy uses natural killer cells, a type of immune cell, to attack the cancer. It may help slow or stop the cancer's growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have stomach or colorectal cancer that cannot be removed with surgery and has not responded to radiation or chemotherapy.
- Your cancer must have progressed or come back after at least two prior treatments.
- You must be able to have at least one tumor measured on a CT or MRI scan.
- You must be in generally good health (able to care for yourself, up and about more than half of your waking hours).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding natural killer (NK) cells to your usual maintenance treatment for advanced solid tumors. NK cells are a type of immune cell that may help your body fight cancer more effectively and delay the cancer from growing.
This trial tests a new type of immune cell therapy (CAR-NK cells) designed to fight advanced colorectal cancer that has spread or cannot be surgically removed. The therapy is customized to target specific protein markers on your cancer cells.
This trial tests a new natural killer (NK) cell therapy, NK510, for people with advanced non-small cell lung cancer who have already tried immunotherapy and it stopped working. The goal is to see if NK510 is safe and can shrink tumors or slow the cancer's growth.
This trial tests a new therapy that uses your own natural killer (NK) cells, modified to better fight cancer and injected directly into your abdomen. It's for people with advanced ovarian cancer who cannot have surgery or whose tumor cannot be fully removed.
This trial tests a new immune cell therapy called NK521 for people with advanced solid tumors like liver or ovarian cancer that have not responded to standard treatment. The therapy may be given as an infusion or into the belly (for those with fluid buildup containing cancer cells).
This trial tests a new cell therapy using special immune cells (PD-1-M1-NK cells) that are designed to attack cancer cells. It is for people with advanced stomach or colorectal cancer that has not responded to at least two prior treatments.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.